🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ironwood Pharmaceuticals, Inc.

IRWD Healthcare
$4.31 +$0.23 (5.64%)
Market Cap: $712.18 M
Gurus Holding
3
Popularity Rank
#3050
% of Shares Held
8.76%
Net Activity (Q2 2026)
-$4.75 M

Guru Ownership Trend

Guru Analysis for Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals, Inc. (IRWD), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $62.4 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.75 M net outflow during the quarter.

Recent activity highlights Chuck Royce who opened a new position. Conversely, Cliff Asness reduced exposure by 14.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$78,108
Total Buy Value
New Buys 1
Additions 0
-$4.82 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Ironwood Pharmaceuticals, Inc. (IRWD)

Major holders include Renaissance Technologies (RenTech) ($33.65 M), Cliff Asness ($27.22 M), Chuck Royce ($78,108). According to the latest reported data, 3 tracked investment managers collectively hold approximately 14.48 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.75 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited IRWD. The total reported sell value was $4.82 M.

Yes, 1 managers opened new positions in IRWD, and 0 increased their existing holdings. The total reported buy value was $78,108.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.05% Reduce -0.8% 7,993,226 $33.65 M Q2 2026
0.01% Reduce -14.2% 6,465,921 $27.22 M Q2 2026
0.00% New Buy 18,553 $78,108 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form